{"name":"NVP Healthcare","slug":"nvp-healthcare","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Ezetrol","genericName":"Ezetrol","slug":"ezetrol","indication":"Familial hypercholesterolemia - heterozygous","status":"phase_1"},{"name":"NVP-2203-R1","genericName":"NVP-2203-R1","slug":"nvp-2203-r1","indication":"Type 2 diabetes","status":"phase_3"},{"name":"NVP-2203-R2","genericName":"NVP-2203-R2","slug":"nvp-2203-r2","indication":"Type 2 diabetes","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"cardiovascular","drugs":[{"name":"NVP-2203","genericName":"NVP-2203","slug":"nvp-2203","indication":"Non-small cell lung cancer, PD-L1 positive","status":"phase_3"},{"name":"NVP-1203-R","genericName":"NVP-1203-R","slug":"nvp-1203-r","indication":"Non-small cell lung cancer, PD-L1 positive","status":"phase_3"},{"name":"NVP-2203-R3","genericName":"NVP-2203-R3","slug":"nvp-2203-r3","indication":"Non-small cell lung cancer, PD-L1 positive","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"NVP-2002","genericName":"NVP-2002","slug":"nvp-2002","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Ezetrol","genericName":"Ezetrol","slug":"ezetrol","phase":"phase_1","mechanism":"Sodium/bile acid cotransporter, Niemann-Pick C1-like protein 1, Niemann-Pick C1-like protein 1","indications":["Familial hypercholesterolemia - heterozygous","Familial hypercholesterolemia - homozygous","Hypercholesterolemia","Hyperlipidemia","Mixed hyperlipidemia"],"catalyst":""},{"name":"NVP-2002","genericName":"NVP-2002","slug":"nvp-2002","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"NVP-2203","genericName":"NVP-2203","slug":"nvp-2203","phase":"phase_3","mechanism":"NVP-2203 is a small molecule that targets the PD-1 receptor.","indications":["Non-small cell lung cancer, PD-L1 positive"],"catalyst":""},{"name":"NVP-1203-R","genericName":"NVP-1203-R","slug":"nvp-1203-r","phase":"phase_3","mechanism":"NVP-1203-R is a small molecule that targets the PD-1 receptor.","indications":["Non-small cell lung cancer, PD-L1 positive"],"catalyst":""},{"name":"NVP-2203-R1","genericName":"NVP-2203-R1","slug":"nvp-2203-r1","phase":"phase_3","mechanism":"NVP-2203-R1 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"NVP-2203-R2","genericName":"NVP-2203-R2","slug":"nvp-2203-r2","phase":"phase_3","mechanism":"NVP-2203-R2 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"NVP-2203-R3","genericName":"NVP-2203-R3","slug":"nvp-2203-r3","phase":"phase_3","mechanism":"NVP-2203-R3 is a small molecule that targets the PD-1 receptor.","indications":["Non-small cell lung cancer, PD-L1 positive"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPTTZ2bEw5WTMtNkZpdW5VaUdLTXZYdnhiUW5JNThNaFg4dVdwUVdheUY1S0VNbVVqbWdCNFF0aTdPVUtjYXFQSTdOcU10amR0S0xfZHVZQnRDdnVaZ2VxMlhvejBrMWYxRnFiYzJLMjgxVXlwTkZGc1NFUFQ0QXhNZENoekI3cW5YVVV2N1hpT0hWenNnWkZWZUtsbUxUeEpDWE4yWmJ3?oc=5","date":"2026-04-05","type":"pipeline","source":"IndexBox","summary":"Asia-Pacific Povidones Market 2026 Analysis and Forecast to 2035 - IndexBox","headline":"Asia-Pacific Povidones Market 2026 Analysis and Forecast to 2035","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQWE81UWU2SWdLUjdhRmtRa0tjdkt3RkMzSWcyQlZVTzhQOUFPSnNnaTJiVHhiWVFYbUVvYTRRODZfbktjeklBTVFGa1F4dkVMS2Q5TGJGTk1EdXBsbFRiSXFERWRPbS03Ti1TZDJOZ2NqUTJmMjFxNUNsYmN4ZmJ4V2gtMk1vNzZPZVBxU1B3Q2Z2RGhaSVV2dVFTdUM?oc=5","date":"2026-04-05","type":"pipeline","source":"IndexBox","summary":"China Povidones Market 2026 Analysis and Forecast to 2035 - IndexBox","headline":"China Povidones Market 2026 Analysis and Forecast to 2035","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPMWVrYkU1VTYtaVQ5TlRYVHVwQXYyaUtUQWdhc0tDT2RmQzF1RXQtVmVNc1k5alBHYTNZellCa0oxSzdqc1Zma0RWWkVuSjBfb2ZRUU5MYWFKQ2pBdEF5VEpUYjVScWdZTVduMXNUUTBaNjZJZzI2MGk4LVZpZ2p0Wkh0OW9UV0cxOFFrSnN4NFVYX3N2d3lQM2pUa0lhMlRiTW5kWDdFQkI?oc=5","date":"2026-04-05","type":"pipeline","source":"IndexBox","summary":"United Kingdom Povidones Market 2026 Analysis and Forecast to 2035 - IndexBox","headline":"United Kingdom Povidones Market 2026 Analysis and Forecast to 2035","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQUWk0TnM5QUY4aEM2SlItbjczWDRQRGQ0c1dMTmNRdnZxSGdmZk9oRk9DRG9TQkx0d3lzZWQtbngzWGlTcnRYbDZQeS0tSXFieHhFQzZ5LVRzN2xiMFV5akl4Ymh5aVpMWmQxbTRXVE5Lbk1nd0d5QS1KTEtTQlN2YWl6Tk1oeEtuSVRSM0lCLUY?oc=5","date":"2026-02-09","type":"regulatory","source":"fda.gov","summary":"Commissioner's National Priority Voucher (CNPV) Pilot Program - fda.gov","headline":"Commissioner's National Priority Voucher (CNPV) Pilot Program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOeURwaVhNTGh2eFFrcTFyZmNRRjhnME1VZGJkYjlvM21selgtQUI0YTdKbDJRZGFVQ1Z2SUtBekIwdEJhVjZsZ0xZYlg0TVoya0NmUTllWkhZRzQ1TmZydERiLUJkdGppZldFdkY2MzdvOXFGLTh0QzF3cjFhUFVLLUtpbVVocU5iUV85ZjhrbjhGOERsREZ5eTFzbWh0RUFBTlJ1Z1VfeEhLQzRuZlN4aDFrS3h6LThKZGRj?oc=5","date":"2025-11-18","type":"pipeline","source":"PR Newswire","summary":"Independent Health to Join MVP Health Care's Family of Companies - PR Newswire","headline":"Independent Health to Join MVP Health Care's Family of Companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxPY045Y0NURklaUDJZdXpqN01QVXhBdVVkaVJ5SVQxdnpnWmdCYnJOdzRVWmcwamNnZEp3dkdsV1lxZVBBdEdWLUYwelhHSWZQT0NBdlBsTXRjMGItUmFod1VQdHYzdHhoQ0dNVndmOVBxWExMNk1zTlc0X211Tm53bXFYMzFrQmx4M19xMEZlV1M2cGxpRVVlNGNMUVkzSmJ5Vjk2YnVseUhIV2x0VVpPdG83QWdQb0YwQl81amxKekQydXpnLWx6Q05IYzc0SzBNOWF1OC1PMmt6V2tKUHZMSUlWRTl6dw?oc=5","date":"2025-11-18","type":"pipeline","source":"WGRZ","summary":"Independent Health to join MVP’s family of companies - WGRZ","headline":"Independent Health to join MVP’s family of companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNVlpGbzUyWW5Nd1psd183WWhaLVY4MEhkUkZyQmZ5d3VpRk0yX2R0ZDJTZzlPdWtMTlF4NXQ2VVA2OWVDckFnNTkwcERZSDlia3NtM3l3RU1JY3VaMXRLaE5oeDVtN0Q3MkdDMFlBbU9WckhJXzFHU3RFMEZGNE9fMGs2NlBaVjl6a2dHQ1dVM3FjLTF1TXVwOUE3d3k4emhEREtYdzRGbEpYalJrYkk1ZjZEd29mQ0NIUVJLbmhrQXhyVDhSQXVyUWpPY2U?oc=5","date":"2025-08-01","type":"regulatory","source":"McKinsey & Company","summary":"Rewiring pharma’s regulatory submissions with AI and zero-based design - McKinsey & Company","headline":"Rewiring pharma’s regulatory submissions with AI and zero-based design - McKinsey & Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE1ZS0d6Yld4ajNpdzlyY3Q0dHBiLUxYZ1Y5ek5tNF9wb3Rac1ViYUxZWmhiZXc4OVp0UzBDX1JRZXRjaER4eWQyUXVlYjNxYUpTQVFmYThGU1JURUt1X0pVRVJxTEctLWhlLS1sazVwVDFiSHdI?oc=5","date":"2025-07-18","type":"pipeline","source":"Businesskorea","summary":"HEM Pharma Opens Advanced Bio-Manufacturing Factory inSejong - Businesskorea","headline":"HEM Pharma Opens Advanced Bio-Manufacturing Factory inSejong","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9IR2hWTVNFVUs1LVVHMVBwSzFyZE01M1Q0V1RpVUpLVUMzaF9RQXp0V1ZBa09mc05KS0xzRklGTGNSZm05SHRrd3d4QWNoMDA1ZE9Pc2dYVGJfazZfbGxzdjFlb0hIa3VVZmQyNjBR0gFyQVVfeXFMT3UtY3h2dXlJdFlUemtCWlBZNkFPM21uQTlOSXB2dXFuR0xSREZwc19OZk9BTHMwU2RXMENjbXlWVXJqMGtkQVhsRW1KeTdTZmIyTE5Rc1pMLWtyLXBfdFo5SFFJZVQ1S2RQSU1SYmcxdGt3?oc=5","date":"2025-06-25","type":"patent","source":"koreabiomed.com","summary":"Daiichi’s hold on Lixiana under pressure as Korean generics target 2026 launch - koreabiomed.com","headline":"Daiichi’s hold on Lixiana under pressure as Korean generics target 2026 launch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPMTZmWUo2MlJtakJ0VmVyUWVUOFFHcldxTnRCVFFIM3hoMjg0QTRFSFo3SnVKVGNKREhLa0R3S3JXQW1hNW9ES24xVHVYMVBGb2cyaEx1WU43eVpuOHRIZFRLLVZHS1k0aUYwdkNjYlhtUzdoZ0xub1J0cHdtSG5EWkRIWnV4djNra3BpLWdPeDJmX3JpWGtfeGhqUWxZS195SzJUTE9hX0dBX0pMZHdOYWo2XzRKQQ?oc=5","date":"2025-05-13","type":"pipeline","source":"VTDigger","summary":"Health insurers ask to increase health plan premiums, amid rising health care costs - VTDigger","headline":"Health insurers ask to increase health plan premiums, amid rising health care costs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQYU9uTHpPZGd3dEhtVThMbF9WQzFhWTcwSng1azFWM1ZNemRrNzE2eW5sLUlmczBfOFl4akh4cWdzM0NMdEt3MXZ0N3lWR3pIMVZIUnp3M3lEV1VlRzcwaVp1RE9iT21ydU1DTUN3S29WeEt0ZkxLSW1OQmJEdEp3MEtScHN1X19ER2plbFk4VUJnYXRUTlRFZk1tUU8tS3Rzel94cG9VakVlY21TUlRwclo2eWhzbkZrTHoxYk5CdDVDQQ?oc=5","date":"2025-05-05","type":"pipeline","source":"eHealth Magazine","summary":"DCGI Greenlights Akums’ Extended-Release NVP Tablet: A First for India’s Pharma Sector - eHealth Magazine","headline":"DCGI Greenlights Akums’ Extended-Release NVP Tablet: A First for India’s Pharma Sector","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxQenN6QjhTZzRnMFF1MmpGVE5SVldoZi02OGRISEV3QUEwU1dvdVJ4RXJYZmRGS2JBSTFMWnVabUpEc3VVdzlpdkxNYWJRR243SW1wU1FpNlpCMHpiNG1OSWNsOC1xc2FLNHBwdVJJNVY1VG12bU43MU1ncTR4bnJrclp0RWVsVDhSalZlYzlmNm5PZ3hWc25OTjA2dDRramZFbDZSaEotb1d6MUF6eC04anoxeG9fRTA3NkFGRkpqMjJZNVVWN1FYMGtaVmVGZWpqYUxUdGJRbEFwVlU4?oc=5","date":"2024-06-06","type":"pipeline","source":"Business Wire","summary":"BranchLab Launches Privacy-Safe Healthcare Advertising Solution with Seed Funding Round - Business Wire","headline":"BranchLab Launches Privacy-Safe Healthcare Advertising Solution with Seed Funding Round","sentiment":"neutral"}],"patents":[],"drugCount":7,"phaseCounts":{"phase_1":2,"phase_3":5},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}